Significant cuts to clinical laboratory reimbursement rates under Medicare and other payors continue to have

a devastating impact on the clinical laboratory in hospitals.

The Dark Report predicts that the Protecting Access to Medicare Act of 2014 (PAMA) has the potential to be the single most financially disruptive event to hit the clinical laboratory industry during the past 25

years.

Both CMS and the Office of the Inspector General (OIG) have stated publicly that the fee cuts planned by CMS will reduce the cost of Medicare lab

testing by $5.4 billion over 10 years.

Reimbursements will continue to decline, and hospitals must reduce

costs accordingly...

That’s why we created Colaborate.Focused exclusively on laboratory improvement, we

help organizations realize concealed financial and operational opportunities.

Over the past 10 years, we’ve identified more than $1 billion

in cost reduction opportunities for our client organizations.

With our proven approach, we find opportunity where others can’t. Average return has been 20X our clients’

investment.

We’ve been honored to serve some of the most recognized names in healthcare, including these organizations…

“We were losing a million dollars a week on our lab ventures when we brought in

Colaborate. Within 90 days, we were breakeven; shortly thereafter, Colaborate

jettisoned the business to a strategic buyer for more than $30 million.”

Jerry Maki

Stanford University

We’ve been honored to serve some of the most recognized names in healthcare, including these organizations…

“Our hospital-based lab was losing seven million dollars a year when Colaborate

arrived. They provided interim leadership and direction; within 6 months the lab was

profitable, and we finished the year earning $5 Million. They are the best

counselors I have ever retained”

Larry HarrisonScripps Clinic

Kevin Hunter | President, CEO & Managing PartnerTel 813-240-4646 | khunter@colaborate.com